|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Anesiva Inc., of South San Francisco, conducted a pre-filing meeting with the FDA and expects to file a new drug application in the September/October time frame for its lead product candidate, 3268, a fast-acting, needle-free, local anesthetic shown to reduce pain associated with venipunctures. If approved, 3268 could be launched in 2007 for the pediatric population.
o Array BioPharma Inc., of Boulder, Colo., received $18 million upon completion of a previously announced transaction involving its Boulder landlord and BioMed Realty Trust Inc., of San Diego, under which Array assigned its option to purchase its facility to BioMed. On July 7, BioMed closed on the ...